| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | N Johnson | |
| T Müller | |||
| A Vos | |||
| A R Fooks | |||
| C Freuling | |||
| N Tordo | |||
| P2860 | cites work | Fatal human infection with rabies-related Duvenhage virus, South Africa | Q24628684 |
| Bats: important reservoir hosts of emerging viruses | Q27473464 | ||
| Chimeric lyssavirus glycoproteins with increased immunological potential | Q33639069 | ||
| Australian bat lyssavirus infection: a second human case, with a long incubation period | Q33911487 | ||
| Screening of active lyssavirus infection in wild bat populations by viral RNA detection on oropharyngeal swabs | Q33973698 | ||
| DNA-based immunization against Lyssaviruses. | Q34184607 | ||
| Survival after treatment of rabies with induction of coma | Q34426806 | ||
| Evolution of European bat lyssaviruses | Q34438652 | ||
| Bats as a continuing source of emerging infections in humans. | Q34573993 | ||
| Rabies surveillance in the United States during 2006. | Q34662744 | ||
| Isolation of Lagos bat virus from water mongoose | Q35793622 | ||
| European bat lyssavirus in Scottish bats | Q35872955 | ||
| Survey for bat lyssaviruses, Thailand | Q35873314 | ||
| Serologic evidence of lyssavirus infection in bats, Cambodia | Q35881079 | ||
| Pivotal role of dogs in rabies transmission, China | Q36009505 | ||
| Lagos bat virus in Kenya | Q36539910 | ||
| Serologic evidence of Lyssavirus infections among bats, the Philippines | Q37320114 | ||
| Host switching in Lyssavirus history from the Chiroptera to the Carnivora orders | Q39606804 | ||
| Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses | Q40505899 | ||
| Characterisation of a novel lyssavirus isolated from Pteropid bats in Australia. | Q41018471 | ||
| Antibodies against Lagos bat virus in megachiroptera from West Africa | Q42119773 | ||
| Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3' non-translated region | Q42615215 | ||
| Complete genomes of Aravan, Khujand, Irkut and West Caucasian bat viruses, with special attention to the polymerase gene and non-coding regions | Q42657452 | ||
| Completion of the rabies virus genome sequence determination: highly conserved domains among the L (polymerase) proteins of unsegmented negative-strand RNA viruses | Q42658674 | ||
| Human rabies of bat origin in Europe | Q43209701 | ||
| Lyssavirus glycoproteins expressing immunologically potent foreign B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines | Q43214557 | ||
| Efficacy of rabies biologics against new lyssaviruses from Eurasia | Q43218841 | ||
| Lyssavirus infection activates interferon gene expression in the brain | Q43221143 | ||
| Susceptibility of sheep to European bat lyssavirus type-1 and -2 infection: a clinical pathogenesis study | Q43222988 | ||
| T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination | Q43832039 | ||
| Susceptibility of North American big brown bats (Eptesicus fuscus) to infection with European bat lyssavirus type 1. | Q44050696 | ||
| Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses | Q44460690 | ||
| Spill-over of European bat lyssavirus type 1 into a stone marten (Martes foina) in Germany | Q44550163 | ||
| An updated list of rabies-infected bats in North America | Q45162689 | ||
| Salivary excretion of rabies virus by healthy vampire bats. | Q45445104 | ||
| Bat rabies in the United States and Canada from 1950 through 2007: human cases with and without bat contact | Q46371351 | ||
| DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses | Q48026662 | ||
| Case report: isolation of a European bat lyssavirus type 2a from a fatal human case of rabies encephalitis | Q48218249 | ||
| Presence of European bat lyssavirus RNas in apparently healthy Rousettus aegyptiacus bats | Q48662677 | ||
| Epidemiology of bat rabies in Germany. | Q53012313 | ||
| First isolation of EBLV-2 in Germany | Q56772992 | ||
| Endemic circulation of European bat lyssavirus type 1 in serotine bats, Spain | Q57003214 | ||
| Indirect oral immunization of captive vampires, Desmodus rotundus | Q57166857 | ||
| European bat lyssaviruses — an ecological enigma | Q93444440 | ||
| The Transmission of Paralytic Rabies in Trinidad by the Vampire Bat (Desmodus Rotundus MurinusWagner, 1840) | Q99759062 | ||
| P433 | issue | 3-4 | |
| P921 | main subject | rabies | Q39222 |
| P304 | page(s) | 151-159 | |
| P577 | publication date | 2010-02-06 | |
| P1433 | published in | Veterinary Microbiology | Q15761011 |
| P1476 | title | Human rabies due to lyssavirus infection of bat origin | |
| P478 | volume | 142 |
| Q33563191 | A two-step lyssavirus real-time polymerase chain reaction using degenerate primers with superior sensitivity to the fluorescent antigen test. |
| Q37698084 | Antigenic and genetic characterization of a divergent African virus, Ikoma lyssavirus |
| Q57093327 | Bacterial diversity of bat guano from Cabalyorisa Cave, Mabini, Pangasinan, Philippines: A first report on the metagenome of Philippine bat guano |
| Q34298720 | Bat rabies surveillance in Europe |
| Q26700071 | Bat-man disease transmission: zoonotic pathogens from wildlife reservoirs to human populations |
| Q61444824 | Characterization of a novel species of adenovirus from Japanese microbat and role of CXADR as its entry factor |
| Q37336363 | Chicken interferon-inducible transmembrane protein 3 restricts influenza viruses and lyssaviruses in vitro |
| Q33853861 | Comparative analysis of European bat lyssavirus 1 pathogenicity in the mouse model |
| Q33918621 | Comparative studies on the genetic, antigenic and pathogenic characteristics of Bokeloh bat lyssavirus |
| Q36246278 | Conservation of a unique mechanism of immune evasion across the Lyssavirus genus. |
| Q30875451 | Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species |
| Q38211810 | Current status of rabies and prospects for elimination |
| Q91907897 | Dampened NLRP3-mediated inflammation in bats and implications for a special viral reservoir host |
| Q47265337 | Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT. |
| Q38031922 | Developments in rabies vaccines |
| Q34117928 | Diseases and causes of death in European bats: dynamics in disease susceptibility and infection rates |
| Q43180549 | Effect of media warnings on rabies postexposure prophylaxis, France |
| Q41926166 | Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2. |
| Q38126807 | Emerging infectious diseases associated with bat viruses |
| Q33552972 | Enhanced passive bat rabies surveillance in indigenous bat species from Germany--a retrospective study |
| Q35312002 | Establishment of Myotis myotis cell lines--model for investigation of host-pathogen interaction in a natural host for emerging viruses |
| Q28656391 | European bats as carriers of viruses with zoonotic potential |
| Q42146352 | First Report on the Efficiency of Oral Vaccination of Foxes against Rabies in Serbia |
| Q42994701 | Haunted with and hunting for viruses |
| Q47098837 | Host Genetic Variation Does Not Determine Spatio-Temporal Patterns of European Bat 1 Lyssavirus |
| Q56766468 | Jet set pets: examining the zoonosis risk in animal import and travel across the European Union |
| Q46259558 | Longitudinal survey of two serotine bat (Eptesicus serotinus) maternity colonies exposed to EBLV-1 (European Bat Lyssavirus type 1): Assessment of survival and serological status variations using capture-recapture models. |
| Q42245887 | Lyssavirus infection: 'low dose, multiple exposure' in the mouse model |
| Q61444668 | Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study |
| Q46249795 | Molecular detection and sequence characterization of diverse rhabdoviruses in bats, China. |
| Q41993857 | Novel lyssavirus in Natterer's bat, Germany |
| Q38006132 | Passive immunity in the prevention of rabies. |
| Q28829448 | Persistence of Rabies Virus-Neutralizing Antibodies after Vaccination of Rural Population following Vampire Bat Rabies Outbreak in Brazil |
| Q38671389 | Potential risk of viral transmission from flying foxes to domestic animals and humans on the southern coast of West Java, Indonesia |
| Q37281773 | Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles. |
| Q35824681 | Real-time Imaging of Rabies Virus Entry into Living Vero cells |
| Q36947050 | The Rabies Virus L Protein Catalyzes mRNA Capping with GDP Polyribonucleotidyltransferase Activity |
| Q92494858 | Transcriptional Control and mRNA Capping by the GDP Polyribonucleotidyltransferase Domain of the Rabies Virus Large Protein |
| Q92258137 | Viral Equine Encephalitis, a Growing Threat to the Horse Population in Europe? |
| Q30363485 | Viral metagenomics on animals as a tool for the detection of zoonoses prior to human infection? |
| Q45372329 | Virus neutralising activity of African fruit bat (Eidolon helvum) sera against emerging lyssaviruses |
| Q54175792 | [Rabies transmission through organ transplantation]. |
Search more.